Swikrity U Baskota,MD, FCAP,FASCP

AssocProf breast/lung path and #cytoPD @pathatUCD, @cytopathology cmtee chair; @CAPFnDN BOD; #ASCP40Underforty @pathologistmag powerlist22/24🇳🇵views my own

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

Thank you for all the votes and support! Beyond grateful! #ASCP40UnderForty! See you at #ASCP2025

[ASCP @ASCP_Chicago]

Congratulations to the 2025 #ASCP40UnderForty Top Five Honorees:

Sophia Bellegarde, MD, MBA, MLS(ASCP)
Yembur Ahmad, MD
June Chan, PhD, D(ABMM), M(ASCP)CM
Swikrity Upadhyay Baskota, MBBS, MD, VCAP, FASCP
Santosh Kadel, DCLS, MS, CC(NRCC), MLS(ASCP)CM

To learn more about each honoree, visit ASCP's 40 Under Forty gallery here: https://t.co/E7YBSYBMq7

[Ana Yuil @ana_yuil]

Excellent ASC podcast: Part 1 Pathology residency training in Latin America and Spain @CeciliaEGimene1 @Glorima31955971 @mdlozanoe @milyabadli @cytopathology @citologiala
https://t.co/j2YdUly4Tf

[Papanicolaou Society @PapSociety]

Save the Date! 🌎🔬
For the first time, @PapSociety and SLAC are coming together for a joint educational collaboration!
Join us for the Milan Masterclass: December 5, 2026 | Online. More details coming soon!
@DianaEstherossi @PoonamVohra3 @CiolyRiveroC @aakasharmand @IACytology

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

Look who we bumped into in Paris! @FridaRosenblum #ECCyto2026 post-trip!

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

@divyasharmamd @IHC_guy @IAPJapan @KDeFelice_IBD @Deyali7 @ambhalla_md @navale_pooja @Shilpaj16oct @TheUSCAP @USGIPS @UCMCGIHEP @UCincyPath Yay @divyasharmamd ! Enjoy IAP

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

@mhassanaimc @Venkateshgilly2 @fouad_boulos @AGrabenstetter @Janiranavarro @VickeryJasmine @kis_lorand @RazaHoda The stroma makes me think it’s invasive no matter what myoep is showing! I sometimes do individual stains for P63 and SMHHC on these cases!

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

@israhkhan @cap @Pathologists @templepathology @katcollmd @IACytology @ZhaiJim @PathologyOnline @philly_path @PAPathologists @ESP_Pathology Congratulations 🎊🎉🍾🎈 Dr.Akhtar! So truly deserved!!

[Cancer Cytopathology @CancerCytopath]

New Review! Diagnostic accuracy of methylthioadenosine phosphorylase IHC for CDKN2A homozygous deletion and for distinguishing mesothelioma from reactive mesothelial proliferations: A systematic review and bivariate meta-analysis

🔗: https://t.co/YdLEylzn26

#CytoPath #IHCPath

[gulcin guler simsek, MD @glinglerimek]

@Baskotacytopath Many many thanks dear friend for your kind message @baskotacytopath

[Cioly Rivero C. @CiolyRiveroC]

#ECCyto2026

@Baskotacytopath @KarenLVZ @CDinares @SECitologia @IACytology @USFNA_SPAIN @EfcsYoung

#cytopath #cytology

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

Wonderful talk! @glinglerimek ! #ECCyto2026

[gulcin guler simsek, MD @glinglerimek]

My eyes welled up; I was deeply moved. Many many thanks dear friend. 😍🙏☺️ #ECC2026

[Christina Zioga @chriszioga]

Dr @JM_CytoBox is shaping the future of #CytoJ with this extra interesting interactive way! #ECCyto2026 @CytopathologyJ

[Christina Zioga @chriszioga]

#ECCyto2026

[Sid Yadav MD, FACP @SidYadavMD]

We are used to thinking about pathogenic variants in BRCA1 and BRCA2 as carrying a high risk of breast and ovarian cancer. But not all BRCA1/2 variants may carry the same risk.
What if the type of variant and where it is located within the gene could help us better estimate an individual’s risk of developing a specific cancer? In this review, we discuss the growing evidence that cancer risk associated with BRCA1 and BRCA2 can vary based on the type and location of the variant, and what that could mean for more precise risk estimation. Precision in risk estimation in BRCA1/2 carriers can help us be better about screening, prevention, and other risk-management strategies. We are slowly but surely moving from gene-level risk toward variant-specific risk and, hopefully, towards a more individualized risk management.

Link to the article: https://t.co/PdP77GvMJt

[Andrew Bellizzi 🇺🇦 @IHC_guy]

Hello Friends! We have an unexpected opening in our @ColumbiaPath Surgical Pathology Fellowship for July 2027.

The fellowship emphasizes graduated responsibility, frozen section coverage, and independent signout.

Inquiries can be addressed to me: [email protected]

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

@MerceJorda1 It was lovely meeting you in person @MerceJorda1 and thank you for all of your insightful suggestions! Until next time :-)

[Christina Zioga @chriszioga]

Our next speaker at the "Beyond the cells" session, a pro on professional use of social media for medical practice, an eloquent lecturer Dr @Baskotacytopath! Come to learn from the best at Tiffany #ECCyto2026

[Cioly Rivero C. @CiolyRiveroC]

Keep your cells together, by @KarenLVZ

Set boundaries - protect your time - make space for yourself 🫵

🔬 We care for cells every day
❤️ Let’s not forget to care for the person behind the microscope.

#BeyondTheCells #Cytopathology #Cytopath #ECCyto2026

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

Thank you for the invite @CiolyRiveroC @chriszioga #ECCyto2026! Lovely to share the platform with @CDinares @KarenLVZ

[Cioly Rivero C. @CiolyRiveroC]

The most important cell is the one we forget to look after: US ❤️

We scrolled through our cells, shared, reflected… and tried to keep our cells together 🔬🤗

Huge thanks to the amazing speakers for making it happen 🌟

#BeyondTheCells #Cytopathology #MoreThanCells #ECCyto2026

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

So proud of these two brilliant ladies @CiolyRiveroC @chriszioga co-chairing our session this morning! #ECCyto2026

[Swikrity U Baskota,MD, FCAP,FASCP @Baskotacytopath]

Wonderful and impactful presentation by @KarenLVZ of professional burden we carry and managing one self while taking care if our patients #ECCyto2026 cc: @chriszioga @CiolyRiveroC @CDinares @KarenLVZ @EfcsYoung @CytologyEFCS